Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Single Ascending Dose Study of PRX002 in Healthy Subjects

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Neotope Biosciences Limited, a subsidiary of Prothena Corporation plc
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Neotope Biosciences Limited, a subsidiary of Prothena Corporation plc
ClinicalTrials.gov Identifier:
NCT02095171
First received: March 14, 2014
Last updated: April 11, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)